BIXINK

Mucosamin® is an adhesive liquid gel used to protect the oral cavity and wounds with low exudate. As a wound dressing, it forms a physical film after being applied to the oral mucosa and surgical wounds to create a moist environment, further it protects the wound from the external environment.

Prevention and improving symptoms of oral mucositis through various clinical trials have been proven to be effective, and the antioxidant effect of hyaluronic acid, the main ingredient in the product, prevents cell damage and forms a physical protective film to help wound regeneration. All ingredients are biomaterials, so it has almost zero side effects and can be used for a long period of time. Mucosamin® does not contain ethanol, thus it optimizes patient compliance. Mucosamin®, which has a moisturizing effect, is a competitive medical device that can also expand to the dry mouth market and has received the CE mark in Europe.

Medical device for Oral Mucositis (OM) and Dry Mouth (DM)

Mucosamin^® is a CE marked medical device and is an oral liquid formulation that helps prevent and treat oral mucositis caused by chemotherapy or radiation therapy. Hyaluronic acid, the main ingredient of mucosamin, prevents cell damage through antioxidant activity and helps wound healing by physically forming a protective film. In addition, the patented cluster of amino acids (Glycine, L-Proline, L-Leucine, L-Lysine), collagen precursor restores mucosal ulcers and protects fibroblasts. Mucosamin^® is a competitive medical device that can also expand to the dry mouth market with hydration effect.